SMARCA4 and adenocarcinoma: In conclusion, a subset of HNF4α-positive adenocarcinomas, such as mucinous adenocarcinomas with gastrointestinal differentiation, are TTF-1-negative and SMARCA4 retained, often showing KRAS mutations.